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AbstrAct
Objective
To examine how a healthy lifestyle is related to life 
expectancy that is free from major chronic diseases.
Design
Prospective cohort study.
setting anD participants
The Nurses’ Health Study (1980-2014; n=73 196) and 
the Health Professionals Follow-Up Study (1986-2014; 
n=38 366).
Main expOsures
Five low risk lifestyle factors: never smoking, body 
mass index 18.5-24.9, moderate to vigorous physical 
activity (≥30 minutes/day), moderate alcohol intake 
(women: 5-15 g/day; men 5-30 g/day), and a higher 
diet quality score (upper 40%).
Main OutcOMe
Life expectancy free of diabetes, cardiovascular 
diseases, and cancer.
results
The life expectancy free of diabetes, cardiovascular 
diseases, and cancer at age 50 was 23.7 years (95% 
confidence interval 22.6 to 24.7) for women who 
adopted no low risk lifestyle factors, in contrast to 
34.4 years (33.1 to 35.5) for women who adopted four 
or five low risk factors. At age 50, the life expectancy 
free of any of these chronic diseases was 23.5 (22.3 
to 24.7) years among men who adopted no low risk 
lifestyle factors and 31.1 (29.5 to 32.5) years in men 
who adopted four or five low risk lifestyle factors. 
For current male smokers who smoked heavily (≥15 
cigarettes/day) or obese men and women (body 
mass index ≥30), their disease-free life expectancies 
accounted for the lowest proportion (≤75%) of total 
life expectancy at age 50.
cOnclusiOn
Adherence to a healthy lifestyle at mid-life is 
associated with a longer life expectancy free of major 
chronic diseases.
Introduction
The average life expectancy in the world has increased 
substantially in the past few decades.1 The aging of 
the population has led to a high prevalence of chronic 
diseases such as diabetes, cardiovascular disease, and 
cancer. Although people live longer, older individuals 
often live with disabilities and chronic diseases.2 
People with chronic diseases including cancer, cardio­
vascular disease, and diabetes have a shorter life 
expectancy than do their peers without these chronic 
conditions.3­5 Estimates of the loss in life years due to 
these chronic conditions range from 7.5 to 20 years, 
depending on the methods used and the characteristics 
of the study population.3­5
Modifiable lifestyle factors including smoking, 
physical activity, alcohol intake, body weight, and diet 
quality affect both total life expectancy and incidence of 
chronic diseases.6­9 Studies have shown that smoking, 
inactivity, poor diet quality, and heavy alcohol con­
sumption contribute up to 60% of premature deaths 
and 7.4­17.9 years’ loss in life expectancy.7 10­15 
Nevertheless, little research has looked at how a 
combination of multiple lifestyle factors may relate 
to life expectancy free from the major diseases of 
diabetes, cardiovascular disease, and cancer.15­19
Because estimates of life expectancy free of chronic 
diseases take into account both morbidity and 
mortality, these estimates can be useful metrics for 
health professionals and the general public, as well 
as enabling policy makers to better estimate future 
healthcare costs and to plan for healthcare needs.20­22 
In a previous analysis, we estimated the effect of 
healthy lifestyles on the overall life expectancy.23 In 
this study, we examine the effect of healthy lifestyle 
factors on life expectancy free of cancer, cardiovascular 
disease, and type 2 diabetes, using data from up to 34 
years of follow­up in the Nurses’ Health Study (NHS) 
and 28 years of follow­up in the Health Professions 
Follow­up Study (HPFS).
Methods
study population
This study was embedded in the NHS and the HPFS. The 
NHS began in 1976, when 121 700 female nurses aged 
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WhAt Is AlreAdy knoWn on thIs topIc
Modifiable lifestyle factors including smoking, physical activity, alcohol use, 
body weight, and diet quality affect both total life expectancy and incidence of 
chronic diseases
Few studies have comprehensively examined how a combination of multiple 
lifestyle factors may relate to life expectancy free from the major diseases such 
as diabetes, cardiovascular disease, and cancer
WhAt thIs study Adds
A healthier lifestyle was associated with an increased total life expectancy and 
life expectancy free of cancer, cardiovascular disease, and type 2 diabetes
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30­55 years were included and provided information on 
medical, lifestyle, and other health related variables.24 
In 1980, 92 468 nurses also completed a validated food 
frequency questionnaire. The HPFS was established 
in 1986, when 51 529 male US health professionals 
(dentists, optometrists, osteopaths, podiatrists, phar­
macists, and veterinarians) aged 40­75 years completed 
a mailed questionnaire about their medical history 
and lifestyle.25 In both cohorts, self administered 
questionnaires have been sent every two years to update 
the information and identify newly diagnosed cases of 
various diseases. For this analysis, we used 1980 as 
the baseline for the NHS and 1986 for the HPFS. We 
excluded participants already diagnosed as having any 
of the three outcomes (cancer, cardiovascular disease, 
and diabetes, n=15 118), those with implausible 
energy intakes (women: <500 or >3500 kcal/day; 
men: <800 or >4200 kcal/day), and those with missing 
values for body mass index, physical activity, alcohol, 
or smoking at baseline (n=17 317), leaving 111 562 
participants (73 196 women and 38 366 men) for 
analysis. Participants who had missing lifestyle factors 
at baseline had similar baseline characteristics to those 
without missing information (supplementary table A).
The NHS and HPFS cohorts were followed across 
the follow­up periods using similar questionnaires 
on diet, exercise, smoking status, and other factors 
(questions on the use of postmenopausal hormone 
replacement therapies and reproduction related 
questions were asked in the NHS only). Information 
on age, ethnicity, use of multivitamins, regular use of 
aspirin, postmenopausal hormone use (NHS only), and 
the presence or absence of a family history of diabetes, 
cancer, or myocardial infarction (in first degree 
relatives) was collected via biennial questionnaires.
assessment of lifestyle behaviors
We derived a healthy lifestyle score based on 
information on five lifestyle factors—diet, smoking, 
physical activity, alcohol consumption, and body mass 
index (BMI). Diet was assessed in the NHS and HPFS 
by using a validated food frequency questionnaire 
assessing how often, on average, a participant had 
consumed a specified amount of a list of foods during 
the previous year.24 Quality of diet was assessed using 
the Alternate Healthy Eating Index (AHEI) score, which 
is significantly associated with risk of cardiovascular 
disease and other chronic diseases in the general 
population.26 We defined a healthy diet as an AHEI 
score in the top 40% of each cohort distribution.7 
Physical activity levels were assessed using a validated 
questionnaire and updated every two to four years.27 
We estimated the number of hours per week spent 
in moderate to vigorous activities (including brisk 
walking) requiring the expenditure of at least 3 
metabolic equivalents of task (METs) per hour. We 
classified low risk as at least 30 minutes of moderate or 
vigorous activity daily (3.5 h/week). Height and weight 
were self reported and used to calculate BMI as weight 
(kg) divided by height (m2). We defined a healthy body 
weight as a BMI in the range of 18.5­24.9.
Self reported smoking status and the number 
of cigarettes smoked were updated biennially. We 
defined never smokers as participants who reported 
never smoking, current smokers as participants who 
reported active smoking on the questionnaire, and ever 
smokers as participants who had smoked in the past 
but did not report active smoking on the time varying 
questionnaire. On each questionnaire, current smokers 
were further classified as smoking one to 14, 15 to 24, 
or 25 or more cigarettes per day. The food frequency 
questionnaire also collected alcoholic beverage 
consumption, including red and white wine separately 
(4 ounces, increasing to 5 ounces in 2006), beer (one 
glass, can, or bottle), and liquor (one drink or shot). 
We multiplied the amount of alcohol in grams per 
specified portion size by servings per day, determined 
the midpoint of the frequency category, and summed 
across all beverages to estimate the average alcohol 
consumption (g/day). We defined moderate alcohol 
consumption as 5­15 g/day for women and 5­30 g/day 
for men, consistent with the guidelines for moderate 
alcohol intake in the US.28
Our previous studies using objective measurements 
had documented the validity of these lifestyle data. 
A previous validation study showed a correlation 
of 0.97 between self reported weight and weight 
measured by a technician.25 The correlations between 
physical activity reported in diaries and that in the 
questionnaire was 0.62 in women and 0.58 in men.27 
29 In addition, independent associations have been 
observed between physical activity and several 
biomarkers of obesity and cardiovascular disease 
risk such as high density lipoprotein cholesterol, 
leptin, and C peptide.30 Validation studies of the 
food frequency questionnaire with dietary records 
indicated an average correlation of 0.63 for all 
nutrients after adjustment for energy intake and 
variation in the seven day dietary records.24 In 
addition, correlations with nutrient biomarkers in 
our study population provided objective evidence for 
the validity of the food frequency questionnaire.31 32 
Correlation coefficients between the food frequency 
questionnaire and four single week diet records for 
ethanol were 0.90 in the NHS and 0.86 in the HPFS.33 
Ethanol intake assessed through the food frequency 
questionnaire was also significantly correlated with 
serum high density lipoprotein cholesterol (r=0.33 
for NHS; r=0.38 for HPFS). Another validation 
study among 2485 women participating in the NHS 
reported that smoking level was strongly associated 
with toenail nicotine concentration (r=0.63).34
For each low risk lifestyle factor, the participant 
received a score of 1 if he or she met the criterion for 
low risk, and 0 otherwise. The sum of these five scores 
together gave a final low risk lifestyle score ranging 
from 0 to 5, with higher scores indicating a healthier 
lifestyle. As the number of cases among the group 
with the highest lifestyle score was small, especially 
mortality among participants with prevalent diseases, 
we combined participants with four or five low risk 
factors into one group.
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Because lifestyle factors may affect mortality risk 
over an extended period of time, to best represent 
long term lifestyle we applied time varying lifestyle 
information during follow­up, in which mortality risks 
were predicted by the repeated measurements of these 
variables during the follow­up periods. The average 
response rate for the lifestyle risk factors during follow­
up was approximately 94% for the NHS and 90% for 
the HPFS. We calculated average levels of lifestyle 
factors by using the latest two repeated measurements 
for our primary analysis of diet, physical activity, and 
alcohol consumption.35 For non­respondents to both 
questionnaires, we used the last available value carried 
forward. For AHEI score and alcohol consumption, 
we calculated the average on the basis of four year 
repeated measurements. Smoking status was estimated 
on the basis of both smoking history and most recent 
status updated every two years and classified into five 
categories: never smoking, past smoking, and current 
smoking of 1­14, 15­24, and 25 or more cigarettes 
per day. To minimize reverse causality, we applied the 
lifelong maximum BMI by age at risk.36 For example, 
we applied the maximum value of BMI at age 18 and 
BMI in 1980 to predict mortality between 1980 and 
1982 and the maximum value of BMI at age 18, BMI 
in 1980, and BMI in 1982 to predict mortality between 
1982 and 1984, and so forth.
ascertainment of deaths and non-fatal chronic 
diseases
In the NHS and HPFS, most of the deaths were 
identified through family members or the postal 
system in response to the follow­up questionnaires. We 
searched the National Death Index to identify deaths 
among all study participants, with a high sensitivity 
(97.7%) and specificity (100%).37
Self reported diagnoses of cancer, myocardial 
infarction, and stroke were collected on biennial 
questionnaires, and participants who reported a 
new diagnosis were asked for permission to acquire 
their medical records and pathologic reports. Study 
physicians, blinded to exposure information, reviewed 
medical records to confirm the diagnosis. We included 
all cancers as outcomes except non­melanoma skin 
cancer. Non­fatal cardiovascular disease outcomes 
comprised non­fatal myocardial infarction and 
non­fatal stroke. We classified non­fatal myocardial 
infarctions as confirmed if the criteria of the World 
Health Organization were met specifically on the 
basis of symptoms and either electrocardiographic 
changes or elevated cardiac enzyme concentrations. 
We classified stroke cases according to the criteria of 
the National Survey of Stroke, which required evidence 
of a neurologic deficit with a sudden or rapid onset 
that persisted for more than 24 hours. Pathologically 
confirmed cerebrovascular conditions that were 
caused by an infection, trauma, or malignancy were 
not counted as outcomes. Cancer, coronary heart 
disease, and stroke events for which confirmatory 
information was obtained by interview or letter but 
without access to medical records were also included 
as outcomes. The overall proportion of cases confirmed 
by medical records in the NHS and HPFS were 82.9% 
for cancer, 74.4% for coronary heart disease, and 
64.5% for stroke.
Cases of type 2 diabetes were identified by self 
report and confirmed by a validated supplementary 
questionnaire.38 39 For cases before 1998, we applied 
the National Diabetes Data Group criteria. We used the 
American Diabetes Association diagnostic criteria for 
confirmation from 1998 onward. The validation of self 
reported type 2 diabetes diagnosis in the NHS has been 
documented previously.38 39
statistical analysis
We used population based multistate life tables 
to calculate the differences in life expectancy and 
years lived with and without major chronic diseases 
for each lifestyle factor and the total lifestyle factor 
score. To assess the association between the number 
of low risk factors and life expectancy free of cancer, 
cardiovascular disease, and type 2 diabetes, we took 
into account three states (disease free, presence of 
disease, and death), and three transitions between 
states (from non­disease to incident disease, from 
non­disease to mortality among participants free of 
major chronic disease, and from disease diagnosis to 
mortality among those with disease). Subsequently, we 
built multistate life tables allowing for the occurrence 
of the transitions. As shown in supplementary figure 
A, all participants started from state 0 at baseline; 
both the period between state 0 and state 1 (before 
disease diagnosis) and the period between state 0 and 
state 2 (without disease) contributed to the estimated 
life expectancy free of cancer, cardiovascular disease, 
or type 2 diabetes; whereas only the patients with 
cancer, cardiovascular disease, or type 2 diabetes after 
diagnosis (from state 1 to state 2) contributed to the 
estimated life expectancy in the presence of the major 
chronic disease.
We built a total of four multistate life tables—one 
for a combination of cancer, cardiovascular disease, 
and type 2 diabetes and three for individual diseases. 
For each multistate life table, we first derived overall 
transition rates by a single year of age in the NHS and 
HPFS, separately, irrespective of the lifestyle factors, 
for three transitions4: mortality among participants 
free of the diseases, incident diseases, and mortality 
among those with the diseases. We considered only the 
first entry into a state and no subsequent disease event, 
and no reversal of state was allowed. Secondly, we 
calculated hazard ratios to assess the relation between 
the number of low risk factors and the three transitions 
by using Cox proportional hazards analyses. We 
used separate time varying Cox proportional hazards 
models to assess the risk of mortality without disease, 
risk of incident disease, and risk of mortality among 
participants with cancer, cardiovascular disease, and 
type 2 diabetes. Thirdly, we calculated proportions 
of low risk factors among the sub­study population 
for each transition. Lastly, we used the hazard ratios 
combined with the overall transition rates and low 
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risk factor proportions in the multistate life table to 
calculate total life expectancy and life expectancy with 
and without diseases for each group of low risk factors. 
The multistate life tables started at age 50 years and 
closed at age 105 years. Models were adjusted for age, 
ethnicity, current multivitamin use, current aspirin 
use, status with regard to a family history of diabetes, 
myocardial infarction, or cancer, and, for women, 
menopausal status and hormone use.
Considering potential bias resulting from changes 
in diet after the diagnosis of certain diseases, we did 
a sensitivity analysis in which we stopped updating 
lifestyle factors at the beginning of the interval in 
which the participant was diagnosed as having 
cancer, cardiovascular disease, or diabetes. In another 
sensitivity analysis, we further classified the past 
smokers according to the years since smoking cessation.
We used SAS version 9.3 to analyze the data. 
Statistical significance was set at a two tailed P value 
of less than 0.05. We used Monte Carlo simulation 
(parametric bootstrapping) with 10 000 runs to calcu­
late the confidence intervals of the life expectancy 
estimation with @RISK 7.5.
patient and public involvement
No patients were involved in setting the research 
question or the outcome measures, nor were they 
involved in the design and implementation of the study. 
We plan to disseminate these findings to participants 
in our annual newsletter and to the general public in 
a press release.
results
Participants with a higher number of low risk life­
style factors were more likely to use multivitamin 
supplements and aspirin (table 1). During 2 270 411 
person years of follow­up of women and 930 201 
person years of follow­up of men, 34 383 deaths were 
recorded (21 344 women and 13 039 men).
life expectancies free of cancer, cardiovascular 
disease, and diabetes in combination
Total life expectancy at age 50 increased with 
increasing number of low risk lifestyle factors: from 
31.7 years to 41.1 years in women and from 31.3 years 
to 39.4 years in men (fig 1). Regardless of the number 
of low risk lifestyle factors, the vast majority of life 
expectancy after 50 was free of cancer, cardiovascular 
disease, or diabetes (fig 1). At age 50, life expectancy 
free of cancer, cardiovascular disease, and diabetes 
was 23.7 (95% confidence interval 22.6 to 24.7), 26.4 
(25.2 to 27.4), 29.1 (28.0 to 30.0), 31.8 (30.8 to 32.8), 
and 34.4 (33.1 to 35.5) years among women who 
adopted zero, one, two, three, and four or five low risk 
lifestyle factors, respectively. Life expectancy free of 
cancer, cardiovascular disease, and diabetes at age 50 
was 23.5 (22.3 to 24.7), 24.8 (23.5 to 26.0), 26.7 (25.3 
to 27.9), 28.4 (26.9 to 29.7), and 31.1 (29.5 to 32.5) 
years among men who adopted zero, one, two, three, 
and four or five low risk lifestyle factors, respectively 
(table 2). The percentage of life expectancy free of 
cancer, cardiovascular disease, and diabetes from 
total life expectancies was 74.8%, 77.6%, 80.1%, 
82.2%, and 83.6% among women (75.3%, 75.8%, 
76.8%, 77.9%, and 79.0% among men) who adopted 
zero, one, two, three, and four or five low risk lifestyle 
factors, respectively.
The increasing trend of life expectancy free of 
cancer, cardiovascular disease, and type 2 diabetes 
associated with increasing number of low risk lifestyle 
factors was observed across the lifespan after age 50 
(supplementary figure B). In the sensitivity analysis 
in which we stopped updating lifestyle factors after 
the diagnosis of cancer, cardiovascular disease, or 
diabetes, women and men with four or five low risk 
lifestyle factors gained 10.0 (9.3 to 10.3) and 7.2 (6.4 
to 7.9) years in their life expectancy free of the major 
chronic diseases, respectively, compared with those 
with zero low risk lifestyle factors.
life expectancies free of cancer, cardiovascular 
disease, or diabetes separately
Women with four or five low risk lifestyle factors had 
10.6 (10.0 to 11.3) years’ longer life expectancy free 
of the major chronic diseases than did women with 
zero low risk lifestyle factors. When we examined the 
diseases independently, among women, four to five 
low risk lifestyle factors were associated with 8.3 (7.8 
to 8.9) years’ longer life expectancy without cancer, 
10.0 (9.3 to 10.6) more years without cardiovascular 
disease, and 12.3 (11.4 to 13.4) more years without 
diabetes (table 2). Among men, compared with those 
with zero low risk lifestyle factors, participants with 
four to five low risk lifestyle factors gained 7.6 (6.8 to 
8.4) years’ longer life expectancy free of major chronic 
diseases: 6.0 (5.4 to 6.7) more years without cancer, 
8.6 (7.9 to 9.4) more years without cardiovascular 
disease, and 10.3 (9.6 to 11.1) more years without 
diabetes (table 2).
life expectancies in presence of cancer, 
cardiovascular disease, and diabetes
Life expectancy in the presence of cancer, cardiovascular 
disease, and diabetes was not appreciably different 
across the groups with different numbers of low risk 
lifestyle factors (fig 1; supplementary figure B), which 
was due to a smaller number of patients in the low 
risk group together with a longer survival time after 
diagnosis of diseases. Compared with the group with 
zero low risk lifestyle factors, the hazard ratios for those 
with four or five low risk lifestyle factors and incident 
cancer, cardiovascular disease, or type 2 diabetes were 
0.5 for women and 0.6 for men (supplementary table 
B), which means a much lower proportion of incident 
cancer, cardiovascular disease, or type 2 diabetes 
among participants with four or five low risk lifestyle 
factors. After diagnosis of these diseases, half of patients 
with cancer who adopted four or five low risk lifestyle 
factors survived up to 22.9 years, whereas half of 
patients with cancer who adopted zero low risk lifestyle 
factors survived only up to 11.0 years (supplementary 
figure C, left); we observed a similar differential 
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survival probability for people with cardiovascular 
disease (supplementary figure C, middle) and diabetes 
(supplementary figure C, right). The percentage of life 
expectancy with presence of cancer, cardiovascular 
disease, or diabetes out of total life expectancy was 
25.2%, 22.4%, 19.9%, 17.8%, and 16.4% among 
women (24.7%, 24.2%, 23.2%, 22.1%, and 21.0% 
among men) who adopted zero, one, two, three, and 
four or five low risk lifestyle factors, respectively.
life expectancies associated with individual 
lifestyle factors
We also estimated the life expectancy related to each 
lifestyle factor separately. A healthy dietary pattern, 
high levels of physical activity, no smoking, moderate 
alcohol consumption, and an optimal BMI were all 
associated with longer life expectancy free of cancer, 
cardiovascular disease, and diabetes (fig 2). The lowest 
proportions of years of life expectancy free of cancer, 
cardiovascular disease, or diabetes as a percentage 
of total life ex pectancies were observed among men 
who smoked heavily (≥15 cigarettes/day) and obese 
men and women (BMI≥30), for whom 75% or less of 
life expectancy at age 50 years was lived free of these 
chronic diseases (fig 2).
In the sensitivity analysis, women who quit smoking 
for more than 10 years and less than 10 years lost 
1.7 and 6.0 years, respectively, of life expectancy free 
of chronic diseases compared with never smokers; 
for men, this was 1.9 and 2.6 years among those 
with more than 10 and less than 10 years smoking 
cessation, respectively (supplementary figure D). 
When we included only four lifestyle factors without 
alcohol, women who adhered to all four low risk 
lifestyle factors had 9.5 years’ (men: 8.8 years) longer 
life expectancy free of the major chronic diseases than 
did those with none of these factors (supplementary 
figure E, left). After further inclusion of moderate 
alcohol consumption, women who adhered to all five 
low risk factors had 12.5 years’ (men: 9.6 years) longer 
life expectancy free of the major chronic diseases than 
did those with none of these factors (supplementary 
figure E, right).
discussion
Using data from two large cohort studies, we observed 
that adherence to a low risk lifestyle was associated 
with a longer life expectancy at age 50 free of major 
chronic diseases of approximately 7.6 years in men 
and 10 years in women compared with participants 
with no low risk lifestyle factors.
comparison with other studies
Our results are consistent with previous studies 
that estimated the individual or clustering effect of 
lifestyle related risk factors on life expectancy with 
table 1 | participants’ characteristics in middle of follow-up period according number of low risk lifestyle factors in 
nurses’ Health study (women) and Health professionals Follow-up study (men). values are numbers (percentages) 
unless stated otherwise*
no of low risk lifestyle factors†
Zero One two three Four or five
nurses’ Health study (1998) (n=11 749) (n=25 048) (n=19 837) (n=9079) (n=2984
Mean (SD) age, years 63.3 (7.1) 63.6 (7.2) 63.7 (7.2) 63.8 (7.1) 63.6 (6.9)
Mean (SD) body mass index 31.0 (5.3) 29.2 (5.5) 26.6 (5.0) 24.4 (3.5) 23.1 (2.1)
Mean (SD) Alternate Healthy Eating Index score 43.0 (6.8) 46.6 (9.2) 51.4 (9.8) 55.3 (9.3) 58.3 (8.1)
Mean (SD) physical activity, h/week 0.5 (1.0) 0.9 (1.8) 1.9 (3.0) 3.5 (3.8) 5.5 (4.3)
Mean (SD) alcohol consumption, g/day 5.0 (10.8) 4.5 (9.1) 5.1 (8.1) 6.1 (7.4) 7.3 (5.5)
Past smoking 9086 (77.5) 11 314 (45.2) 6822 (34.4) 2658 (29.3) 558 (18.6)
Current smoking 2663 (22.5) 3249 (13.0) 1654 (8.4) 409 (4.5) 50 (1.7)
White 11 524(98.1) 24 496 (97.8) 19 289 (97.2) 8839 (97.4) 2921 (97.9)
Multivitamin use 5412 (46.1) 12 437 (49.6) 10 480 (52.8) 5220 (57.5) 1765 (59.1)
Regular aspirin use 5212 (44.5) 11 457 (45.7) 9145 (46.1) 4358 (47.9) 1535 (51.6)
Family history of diabetes 3583 (30.5) 7394 (29.5) 5296 (26.7) 2170 (23.9) 690 (23.1)
Family history of cancer 1549 (13.3) 3438 (13.7) 2721 (13.7) 1236 (13.6) 419 (14.1)
Family history of myocardial infarction 3153 (26.8) 6273 (25.1) 4787 (24.1) 2069 (22.8) 705 (23.6)
Health professionals’ Follow-up study (1998) (n=4052) (n=10 043) (n=10 706) (n=7252) (n=3710)
Mean (SD) age, years 64.3 (9.1) 64.0 (9.2) 63.7 (9.1) 63.7 (9.1) 63.5 (8.9)
Mean (SD) body mass index 29.2 (3.8) 28.2 (3.7) 26.9 (3.5) 25.7 (3.1) 24.2 (2.2)
Mean (SD) Alternate Healthy Eating Index score 42.5 (7.1) 45.6 (9.0) 50.1 (10.1) 54.4 (10.0) 58.9 (8.9)
Mean (SD) physical activity, h/week 0.8 (1.2) 1.9 (3.8) 3.7 (5.6) 5.9 (6.6) 8.0 (7.2)
Mean (SD) alcohol consumption, g/day 13.1 (21.2) 10.6 (15.4) 10.4 (12.4) 10.8 (10.5) 11.3 (8.2)
Past smoking 3465 (85.4) 6256 (62.2) 5258 (49.2) 2711 (37.4) 624 (16.9)
Current smoking 587 (14.6) 848 (8.5) 491 (4.6) 172 (2.4) 21 (0.6)
White 3814 (94.1) 9441 (94.0) 10 117 (94.5) 6818 (94.0) 3526 (95.0)
Multivitamin use 1520 (37.3) 4247 (42.3) 5092 (47.6) 3804 (52.5) 2135 (57.6)
Regular aspirin use 2020 (49.7) 5349 (53.3) 6014 (56.2) 4250 (58.6) 2264 (61.0)
Family history of diabetes 861 (21.2) 2090 (20.8) 2159 (20.2) 1510 (20.8) 709 (19.2)
Family history of cancer 1291 (31.7) 3445 (34.3) 3824 (35.7) 2641 (36.4) 1422 (38.5)
Family history of myocardial infarction 1300 (32.0) 3143 (31.3) 3412 (31.9) 2336 (32.2) 1248 (33.8)
*Values other than age are standardized to age distribution of study population.
†Included cigarette smoking (never smoking), physical activity (≥3.5 h/week moderate to vigorous intensity activity), high diet quality (upper 40% of 
Alternate Healthy Eating Index), moderate alcohol intake of 5-15 g/day (women) or 5-30 g/day (men), and normal weight (body mass index 18.5-24.9).
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and without chronic diseases.15­19 Ferrucci et al 
found that participants aged 65 years who had never 
smoked and had higher levels of physical activity 
had life expectancies without disability (self reported 
need for help or inability to perform basic activities of 
daily living) of 6.7 years (men) and 7.3 years (women) 
higher than their peers who had ever smoked and had 
low levels of physical activity.16 The Framingham Heart 
Study showed that achieving high levels of physical 
activity, having a normal weight, and never smoking 
was associated with lower risk of cardiovascular 
disease, higher total life expectancy, and greater 
number of years lived free of cardiovascular disease.17 
A large study in Europe found that people with no 
behavior related risk factors lived six years longer 
without chronic diseases (cardiovascular disease, 
cancer, respiratory disease, and diabetes) than did 
participants with at least two behavior related risk 
factors (including smoking, physical inactivity, and 
obesity).18 The CHANCES study found that a healthy 
lifestyle was associated with a 7.4­15.7 years longer 
life expectancy at age 50 years and that most of these 
extra life years were free of chronic diseases.15 Our 
study extends previous findings by comprehensively 
assessing five lifestyle risk factors and three major 
chronic diseases in combination and by providing 
broader estimates of longevity and the number of years 
lived with and without disease in relation to lifestyle 
factors individually and in combination.
We observed a relatively longer gain in life 
expectancy free of diabetes associated with a low 
risk lifestyle than the gained life expectancy free of 
cancer or cardiovascular disease; this was consistent 
with the result of different preventable attribution 
fractions for lifestyle related to specific diseases: 
in our cohorts, 90% of diabetes, 80% of coronary 
heart disease, 70% of cardiovascular mortality, and 
50% of cancer mortality were attributable to not 
following a low risk lifestyle.9 23 38 We did not observe 
a significant difference in life expectancy with cancer, 
cardiovascular disease, and type 2 diabetes across 
the number of low risk lifestyle factors. However, this 
does not necessarily imply that a healthy lifestyle has 
no effect on patients with these conditions. At the 
population level, the overall life expectancy living 
with diseases was determined by both the proportion 
of the population having the diseases and how long 
they survived after diagnosis. Compared with those 
with zero low risk lifestyle factors, men and women 
with four or five low risk factors had a lower rate of 
incident cancer, cardiovascular disease, and type 2 
diabetes, and they also lived longer after diagnosis 
of these diseases. This resulted in a paradoxical non­
differential life expectancy in the presence of cancer, 
cardiovascular disease, and type 2 diabetes across 
groups with different numbers of healthy lifestyle 
factors. A healthy lifestyle not only decreased the 
risk of incident cancer, cardiovascular disease, and 
type 2 diabetes but also improved the survival after 
diagnosis of those diseases.4 15 17 Thus, the proportion 
of years of life living with chronic diseases was higher 
among participants who adhered to an unhealthy 
lifestyle.
Compared with men, women gained a longer life 
expectancy free of major chronic diseases through 
adherence to a low risk lifestyle, resulting from the 
relatively stronger association between low risk 
lifestyle and incident cancer, cardiovascular disease, 
diabetes, and mortality among women than men, as 
observed in our study. Sex differences in the association 
between lifestyles and healthy life expectancy were 
also observed in previous studies, but the reasons 
for this disparity are not clear.15­19 We observed a 
relatively small difference in life expectancies across 
different levels of alcohol consumption compared with 
other individual lifestyle factors. The cardiovascular 
benefits of moderate alcohol consumption have been 
consistently observed in large cohort studies,40 but 
alcohol consumption and risk of cancer showed a dose­
response relation.41 42 Thus, current guidelines do not 
encourage a non­alcohol drinker to start drinking just 
for the benefit of preventing cardiovascular disease.
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Fig 1 | estimated life expectancy at age 50 years with and without cancer, 
cardiovascular disease (cvD), and/or type 2 diabetes among participants of nurses’ 
Health study (women) and Health professionals Follow-up study (men) according to 
number of low risk lifestyle factors. low risk lifestyle factors included cigarette smoking 
(never smoking), physical activity (≥3.5 hours/week moderate to vigorous intensity 
activity), high diet quality (upper 40% of alternate Healthy eating index), moderate 
alcohol intake of 5-15 g/day (women) or 5-30 g/day (men), and normal weight (body 
mass index <25). estimates of multivariate adjusted hazard ratios (sex specific) for 
morbidity and mortality associated with low risk lifestyles compared with people with 
zero low risk lifestyle factors adjusted for age, ethnicity, current multivitamin use, 
current aspirin use, family history of diabetes, myocardial infarction, or cancer, and 
menopausal status and hormone use (women only)
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strengths and limitations of study
Major strengths of this study are the long term follow­up 
of two large cohorts with low rates of loss to follow­up 
and the detailed and repeated measurements of lifestyle 
factors that enabled us to take the dynamic changes in 
lifestyle factors over time into account. Nevertheless, 
we also acknowledge several limitations. Firstly, 
this study was limited by its reliance on self reported 
lifestyle factors; measurement errors are inevitable. The 
use of prospectively collected, cumulatively averaged 
values based on repeated assessments would reduce 
the effect of random measurement errors. Secondly, 
residual and unmeasured confounding might also 
exist even though we controlled for a wide range of 
potential confounders. However, only a very strong 
unmeasured risk factor for mortality together with 
a very large prevalence imbalance among exposure 
groups could explain such strong findings.43  44 
Thirdly, we included only cancer, cardiovascular 
disease, and type 2 diabetes because these are highly 
prevalent diseases, accounting for most chronic 
diseases, and their associations with lifestyle factors 
are well documented. The calculated “disease­free” 
life expectancy would change if we included other 
diseases, such as respiratory disease or kidney disease; 
however, the relative differences in disease­free life 
expectancy across different lifestyle groups should 
not materially change. Similarly, we did not take into 
account the severity and clinical complications of the 
diseases, which could have affected life expectancies. 
Fourthly, people may have changed their lifestyle after 
diagnosis of diseases. Nevertheless, our sensitivity 
analysis taking into account this potential bias showed 
similar results. Lastly, because our study populations 
consist of mostly white health professionals who have 
adopted relatively healthy behaviors, the results may 
not be generalizable to other populations. Therefore, 
further studies are warranted to replicate our findings 
in other ethnic and racial groups and people with 
other professional backgrounds. However, the biologic 
effects of unhealthy behaviors are likely to apply to 
other populations, and the relative homogeneity of the 
study populations in educational attainment, health 
awareness, and socioeconomic status reduces residual 
confounding and enhances the internal validity.
conclusion and public health implications
We observed that a healthier lifestyle was associated 
with a lower risk of cancer, cardiovascular disease, 
and diabetes as well as mortality, with an increased 
total life expectancy and number of years lived 
free of these diseases. Our findings suggest that 
promotion of a healthy lifestyle would help to reduce 
the healthcare burdens through lowering the risk 
of developing multiple chronic diseases, including 
cancer, cardiovascular disease, and diabetes, and 
extending disease­free life expectancy. Public policies 
for improving food and the physical environment 
table 2 | life expectancy (in years) at age 50 years in absence of chronic diseases according to number of low risk lifestyle factors in nurses’ Health 
study (women) and Health professionals Follow-up study (men) separately
no of low risk lifestyle factors*
Zero One two three Four or five
Women
Free of cancer, CVD, or type 2 diabetes:
 Life expectancy 23.7 (22.6 to 24.7) 26.4 (25.2 to 27.4) 29.1 (28.0 to 30.0) 31.8 (30.8 to 32.8) 34.4 (33.1 to 35.5)
 Difference Reference 2.6 (2.3 to 2.9) 5.3 (5.0 to 5.6) 8.1 (7.7 to 8.5) 10.6 (10.0 to 11.3)
Free of cancer:
 Life expectancy 27.6 (26.3 to 28.7) 29.7 (28.5 to 30.9) 31.8 (30.6 to 32.8) 33.8 (32.7 to 34.8) 35.9 (34.6 to 37.1)
 Difference Reference 2.2 (1.9 to 2.4) 4.2 (4.0 to 4.5) 6.2 (5.9 to 6.6) 8.3 (7.8 to 8.9)
Free of CVD:
 Life expectancy 30.2 (29.9 to 30.6) 32.6 (32.2 to 33.0) 35.0 (34.5 to 35.4) 37.6 (37.0 to 38.1) 40.2 (39.5 to 40.9)
 Difference Reference 2.4 (2.1 to 2.7) 4.7 (4.4 to 5.1) 7.3 (6.9 to 7.7) 10.0 (9.3 to 10.6)
Free of type 2 diabetes:
 Life expectancy 28.2 (27.0 to 29.3) 31.1 (30.1 to 32.0) 34.3 (33.6 to 35.0) 37.6 (37.0 to 38.3) 40.5 (39.7 to 41.3)
 Difference Reference 2.9 (2.6 to 3.2) 6.1 (5.6 to 6.6) 9.4 (8.7 to 10.2) 12.3 (11.4 to 13.4)
Men
Free of any of cancer, CVD, or type 2 diabetes
 Life expectancy 23.5 (22.3 to 24.7) 24.8 (23.5 to 26.0) 26.7 (25.3 to 27.9) 28.4 (26.9 to 29.7) 31.1 (29.5 to 32.5)
 Difference Reference 1.2 (0.8 to 1.6) 3.2 (2.7 to 3.6) 4.8 (4.3 to 5.4) 7.6 (6.8 to 8.4)
Free of cancer:
 Life expectancy 27.3 (25.8 to 28.5) 28.3 (26.8 to 29.6) 29.7 (28.2 to 31.1) 31.0 (29.4 to 32.4) 33.3 (31.6 to 34.8)
 Difference Reference 1.0 (0.7 to 1.3) 2.5 (2.1 to 2.8) 3.7 (3.3 to 4.2) 6.0 (5.4 to 6.7)
Free of CVD:
 Life expectancy 29.0 (28.5 to 29.6) 30.6 (29.9 to 31.1) 32.8 (32.1 to 33.4) 34.5 (33.8 to 35.2) 37.7 (36.8 to 38.6)
 Difference Reference 1.5 (1.1 to 1.9) 3.7 (3.3 to 4.2) 5.5 (5.0 to 6.0) 8.6 (7.9 to 9.4)
Free of type 2 diabetes:
 Life expectancy 28.0 (27.3 to 28.7) 29.8 (29.0 to 30.6) 32.6 (31.7 to 33.4) 34.9 (34.0 to 35.8) 38.4 (37.3 to 39.4)
 Difference Reference 1.7 (1.3 to 2.1) 4.5 (4.1 to 5.0) 6.9 (6.3 to 7.4) 10.3 (9.6 to 11.1)
CVD=cardiovascular diseases.
*Included cigarette smoking (never smoking), physical activity (≥3.5 h/week moderate to vigorous intensity activity), high diet quality (upper 40% of Alternate Healthy Eating Index), moderate 
alcohol intake of 5-15 g/day (women) or 5-30 g/day (men), and normal weight (body mass index 18.5-24.9). Multivariate adjusted hazard ratios (sex specific) for mortality and incident diseases 
associated with lifestyles factors adjusted for age, ethnicity, current multivitamin use, current aspirin use, family history of diabetes, myocardial infarction, or cancer, and menopausal status and 
hormone use (women only).
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conducive to adopting a healthy diet and lifestyle, as 
well as relevant policies and regulations (for example, 
smoking ban in public places or trans­fat restrictions), 
are critical to improving life expectancy, especially life 
expectancy free of major chronic diseases.
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Fig 2 | estimated life expectancy at age 50 years with and without cancer, cardiovascular disease (cvD), and/or type 2 diabetes among participants 
of nurses’ Health study (women) and Health professionals Follow-up study (men) according to levels of individual lifestyle risk factors. estimates of 
multivariate adjusted hazard ratios (sex specific) for morbidity and mortality associated with low risk lifestyles compared with people with zero low 
risk lifestyle factors adjusted for age, ethnicity, current multivitamin use, current aspirin use, family history of diabetes, myocardial infarction, or 
cancer, and menopausal status and hormone use (women only). aHei=alternate Healthy eating index; bMi=body mass index; F=fifth. *cigarettes/
day. †Hours/week. ‡grams/day
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